A patient has been diagnosed with a pulmonary embolism and deep vein thrombosis. The healthcare provider has ordered the initiation of low-molecular-weight heparin (LMWH). Which nursing intervention is most important to prioritize to ensure safe administration of this medication?

C) Assess the patient's renal function before administering the medication.

A) Monitor the patient's platelet count for signs of thrombocytopenia.

B) Educate the patient on signs of bleeding and when to report them.

C) Assess the patient's renal function before administering the medication.

D) Ensure the patient is adequately hydrated to prevent further clot formation.

A patient is diagnosed with a pulmonary embolism and deep vein thrombosis. The healthcare team is considering the use of anticoagulant therapy. What is the primary goal of initiating anticoagulation therapy in this patient?

B) To prevent further thrombus formation and reduce the risk of additional embolic events

A) To dissolve the existing thrombus in the pulmonary artery

B) To prevent further thrombus formation and reduce the risk of additional embolic events

C) To improve the patient's cardiac output by enhancing venous return

D) To directly increase the oxygen-carrying capacity of the blood

A patient with a confirmed pulmonary embolism is experiencing increased respiratory distress and hypoxemia despite being on low-molecular-weight heparin. A repeat CT scan shows thrombus extension into the main pulmonary artery. Considering these findings, what is the most appropriate nursing intervention to prioritize at this time?

B) Prepare the patient for the initiation of intravenous unfractionated heparin therapy.

A) Administer a higher dose of low-molecular-weight heparin.

B) Prepare the patient for the initiation of intravenous unfractionated heparin therapy.

C) Increase the patient's supplemental oxygen to 100% via non-rebreather mask.

D) Request an immediate consult with a respiratory therapist for ventilatory support.

A patient with a pulmonary embolism is showing signs of respiratory distress and anxiety after starting low-molecular-weight heparin therapy. The repeat CT pulmonary angiography shows an extension of the thrombus into the main pulmonary artery. What is the most appropriate initial nursing action?

A) Increase the supplemental oxygen flow rate

B) Place the patient in a high Fowler's position

C) Notify the healthcare provider of the changes

D) Start an intravenous infusion of unfractionated heparin

A patient with a pulmonary embolism is on a high-flow nasal cannula due to hypoxemia and has been experiencing mild hemoptysis. The healthcare team is considering thrombolytic therapy. Which of the following assessments should the nurse prioritize to ensure patient safety before initiating thrombolytic therapy?

B) Assessing for contraindications to thrombolytic therapy, such as recent surgery or active bleeding

A) Monitoring for signs of respiratory distress and worsening hypoxemia

B) Assessing for contraindications to thrombolytic therapy, such as recent surgery or active bleeding

C) Evaluating the patient's pain level and administering analgesics as needed

D) Checking the patient's electrolyte levels and renal function

A patient with a history of pulmonary embolism is experiencing respiratory acidosis and hypoxemia despite supplemental oxygen. The healthcare team has decided to transition the patient to high-flow nasal cannula (HFNC) to improve oxygenation. What is the primary reason for choosing HFNC over a standard nasal cannula in this scenario?

A) HFNC provides positive pressure to reduce atelectasis, improving alveolar ventilation.

B) HFNC increases the concentration of carbon dioxide exhaled, reducing respiratory acidosis.

C) HFNC delivers oxygen directly to the alveoli, bypassing the upper airways.

D) HFNC prevents pulmonary embolism progression by increasing blood flow in the pulmonary arteries.

A patient with a large pulmonary embolism is started on thrombolytic therapy. What is the nurse's priority action if the patient begins to exhibit signs of bleeding?

B) Notify the healthcare provider immediately

A) Increase the infusion rate of the thrombolytic agent

B) Notify the healthcare provider immediately

C) Apply pressure to any external bleeding sites

D) Administer a blood transfusion immediately

A patient with a confirmed large pulmonary embolism is undergoing high-flow nasal cannula oxygen therapy and is being considered for thrombolytic therapy due to hemodynamic instability. Which nursing intervention is most critical to prioritize in this scenario?

B) Preparing emergency equipment and medications for potential adverse reactions to thrombolytic therapy

A) Monitoring the patient's urine output hourly to assess renal function

B) Preparing emergency equipment and medications for potential adverse reactions to thrombolytic therapy

C) Educating the patient and family about the potential side effects of thrombolytic therapy

D) Encouraging the patient to ambulate frequently to prevent deep vein thrombosis

A patient receiving thrombolytic therapy for a pulmonary embolism shows a drop in hemoglobin levels and an elevated INR. The patient also reports mild chest discomfort. Which action should the nurse prioritize?

B) Notify the healthcare provider about the chest discomfort and lab results.

A) Administer a pain reliever for the chest discomfort.

B) Notify the healthcare provider about the chest discomfort and lab results.

C) Increase the frequency of vital signs monitoring.

D) Educate the patient about the expected side effects of thrombolytic therapy.

A patient receiving thrombolytic therapy for acute pulmonary embolism shows an improvement in oxygen saturation but a drop in hemoglobin levels. Which nursing intervention is the priority at this time?

B) Increase the frequency of vital signs monitoring to every 15 minutes.

A) Notify the healthcare provider about the drop in hemoglobin levels.

B) Increase the frequency of vital signs monitoring to every 15 minutes.

C) Prepare the patient for possible transfusion of packed red blood cells.

D) Educate the patient about the importance of reporting any new bleeding symptoms immediately.

Deep vein thrombosis that develops into a pe - Nursing Case Study

Pathophysiology

• Primary mechanism: Blood stasis occurs in the deep veins, often of the legs, due to prolonged immobility or venous insufficiency, leading to clot formation. This is part of Virchow's Triad, which also includes vessel wall injury and hypercoagulability.

• Secondary mechanism: The formed clot can dislodge, becoming an embolus. It travels through the venous system and reaches the pulmonary circulation, where it can lodge in the pulmonary arteries.

• Key complication: Pulmonary embolism (PE) occurs when the embolus obstructs blood flow in the pulmonary arteries, impairing oxygen exchange and potentially leading to respiratory distress, decreased cardiac output, and, in severe cases, cardiogenic shock or death. Recognizing early symptoms such as sudden shortness of breath or chest pain is crucial for prompt intervention.

Patient Profile

Demographics:

62-year-old female, retired school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Varicose veins

• Current medications: Metformin, Lisinopril, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath and chest pain

• Key symptoms: Swelling and pain in the left leg, rapid heartbeat, lightheadedness, mild cough

• Vital signs: Blood pressure 145/92 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 99.1°F, oxygen saturation 90% on room air

Section 1

New Diagnostic Results:

Following the initial presentation, the healthcare team promptly initiates a series of diagnostic tests to confirm the suspected pulmonary embolism and assess the extent of the condition. A Doppler ultrasound of the left leg reveals a thrombus in the popliteal vein, confirming the presence of deep vein thrombosis. To evaluate the respiratory distress and chest pain, a CT pulmonary angiography is performed, which demonstrates a filling defect in the right lower lobe pulmonary artery, consistent with a pulmonary embolism. Laboratory tests reveal an elevated D-dimer level of 1,200 ng/mL, which further supports the diagnosis of thromboembolism.

In light of these findings, the clinical team must consider the implications for treatment and ongoing monitoring. The patient's risk factors, including her history of hypertension, Type 2 diabetes, and varicose veins, along with her current symptoms, suggest a complex interplay of cardiac and respiratory challenges. It becomes crucial to establish a comprehensive management plan that addresses anticoagulation to prevent further clot formation and improve oxygenation to address the compromised pulmonary function. This plan may include the initiation of low-molecular-weight heparin or direct oral anticoagulants, alongside supplemental oxygen therapy to maintain adequate oxygen saturation levels.

Through these diagnostic insights, the healthcare team is better equipped to anticipate potential complications such as hemodynamic instability or recurrent embolic events. This necessitates vigilant monitoring of the patient's vital signs, cardiac rhythm, and respiratory status. The integration of these diagnostic results into the patient's care plan exemplifies the importance of connecting clinical findings with targeted interventions, ensuring a proactive approach to managing this multifaceted medical condition.

Section 2

Change in Patient Status:

Shortly after the initiation of anticoagulation therapy with low-molecular-weight heparin and supplemental oxygen, the patient's clinical status begins to evolve. Nurses observe a sudden increase in her respiratory rate, now at 28 breaths per minute, and a decrease in oxygen saturation levels to 88% on room air, indicating a worsening of her respiratory compromise. Her heart rate rises to 110 beats per minute, and she begins to exhibit signs of anxiety and restlessness. These changes necessitate an immediate reassessment of her condition to determine the underlying cause and appropriate adjustments to her treatment plan.

In response to the patient's deteriorating status, a repeat CT pulmonary angiography is performed, revealing an extension of the thrombus into the main pulmonary artery, suggesting a more extensive pulmonary embolism than initially detected. This finding correlates with the increased respiratory distress and hypoxemia observed. Meanwhile, laboratory tests show a further elevation of D-dimer levels to 1,500 ng/mL, reinforcing the progression of thromboembolic activity. Given these developments, the healthcare team must reassess the adequacy of the current anticoagulation regimen, considering a potential shift to intravenous unfractionated heparin for more aggressive anticoagulation management.

The patient's change in clinical status underscores the importance of continuous monitoring and timely reassessment in managing complex conditions like pulmonary embolism with underlying deep vein thrombosis. This scenario highlights the need for clinical vigilance and the ability to adapt treatment strategies in response to evolving patient needs. The healthcare team must now focus on stabilizing the patient's respiratory status while preventing further embolic events, ensuring that all interventions are closely aligned with the latest diagnostic insights.

Section 3

As the healthcare team implements the shift to intravenous unfractionated heparin, the patient's clinical status continues to be closely monitored. Despite the adjustment in anticoagulation therapy, the patient experiences a new complication: she begins to develop mild hemoptysis, characterized by coughing up small amounts of blood-tinged sputum. Her respiratory rate remains elevated at 28 breaths per minute, and her oxygen saturation has slightly improved to 90% with supplemental oxygen at 4 liters per minute via nasal cannula. However, her blood pressure begins to trend downward, now reading 100/60 mmHg, indicating potential hemodynamic compromise.

This new development prompts the healthcare team to consider the possibility of pulmonary infarction or increased pulmonary artery pressure as contributing factors to her condition. An arterial blood gas analysis is performed, revealing a pH of 7.32, PaCO2 of 48 mmHg, and PaO2 of 60 mmHg, suggesting respiratory acidosis with hypoxemia. These findings necessitate further intervention to stabilize her respiratory function and address the underlying causes of her deteriorating condition.

In response, the team initiates a more aggressive oxygen therapy regimen, transitioning the patient to a high-flow nasal cannula to improve oxygenation. Additionally, a consult with a pulmonologist is requested to evaluate the need for further imaging or potential interventions, such as thrombolytic therapy, to address the extensive pulmonary embolism. The team remains vigilant, recognizing the importance of closely monitoring for signs of bleeding due to the intensified anticoagulation therapy, while also ensuring that the patient's hemodynamic status is continuously assessed to prevent further complications. This careful balancing act underscores the complexity of managing acute pulmonary embolism with concurrent complications, requiring coordinated efforts and timely decision-making to optimize patient outcomes.

Section 4

As the patient is transitioned to a high-flow nasal cannula, her respiratory status is closely monitored for any signs of improvement. Within the first few hours, the healthcare team notes a slight increase in her oxygen saturation levels, now at 92%, which is a positive indication that the aggressive oxygen therapy is beginning to take effect. However, her respiratory rate remains elevated at 26 breaths per minute, and her work of breathing seems labored, as evidenced by the use of accessory muscles. The patient's blood pressure remains on the lower side, fluctuating between 98/58 mmHg and 102/60 mmHg, keeping the team vigilant about her hemodynamic stability.

In response to these findings, a decision is made to perform a follow-up chest CT angiography to evaluate the extent of the pulmonary embolism and to assess for any new developments, such as pulmonary infarction. The imaging reveals that there is indeed a large embolus in the right pulmonary artery, contributing to the elevated pulmonary artery pressures and the persistent hypoxemia. Additionally, there are signs of a small area of pulmonary infarction, which correlates with the mild hemoptysis observed earlier. These results confirm the clinical suspicion and underscore the need for continued aggressive management.

The pulmonologist, after reviewing the imaging and clinical findings, recommends initiation of thrombolytic therapy, given the significant clot burden and the patient's hemodynamic compromise. This intervention carries the risk of bleeding, necessitating a delicate balance between dissolving the clot and preventing hemorrhagic complications. The team prepares to administer the thrombolytic agent, while ensuring that emergency protocols are in place to address any adverse reactions. This pivotal decision marks the next phase in the patient's treatment plan, highlighting the complexity of managing severe pulmonary embolism and the critical importance of interdisciplinary collaboration in optimizing patient outcomes.

Section 5

As the thrombolytic therapy is initiated, the healthcare team closely monitors the patient for any signs of improvement or complications. Within the first hour, the patient's oxygen saturation improves further to 94%, providing a tentative indication that the therapy may be effective in reducing the embolic burden. Her respiratory rate decreases slightly to 24 breaths per minute, and while she is still using accessory muscles, her overall work of breathing appears less labored. These subtle improvements offer a glimmer of hope, yet the team remains cautious, aware of the potential for bleeding associated with thrombolytic agents.

Concurrently, the patient's laboratory results return, showing a slight drop in hemoglobin levels from 12.5 g/dL to 11.2 g/dL, raising concerns about potential bleeding. Her platelet count remains stable at 150,000/mm³, but coagulation studies reveal an elevated INR of 2.5, which is higher than expected given her anticoagulation therapy. The nursing staff diligently assess for any overt signs of bleeding, such as changes in mental status or unexplained bruising, to catch any complications early.

As the evening progresses, the patient's blood pressure begins to stabilize slightly, fluctuating between 104/62 mmHg and 110/64 mmHg, suggesting some hemodynamic improvement. However, she begins to complain of mild chest discomfort, prompting the team to consider whether this is a side effect of the thrombolytic therapy or a sign of further complications, such as re-embolization or myocardial strain. The interdisciplinary team gathers to discuss these developments, weighing the benefits of continuing the current therapeutic approach against the potential risks, and strategizing on the next steps to ensure the patient's safety and recovery. This ongoing assessment and decision-making process underscores the complexity of managing acute pulmonary embolism and the necessity for ongoing vigilant monitoring and adaptive treatment strategies.